Bays, Harold E <br/><br/>
A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.  [electronic resource] 

 -  Clinical therapeutics  Nov 2004 
 - 1758-73 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0149-2918 
<br/><br/><label>Standard No.: </label>10.1016/j.clinthera.2004.11.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Alanine Transaminase--blood<br/>Anticholesteremic Agents--administration & dosage<br/>Aspartate Aminotransferases--blood<br/>Azetidines--administration & dosage<br/>Cholesterol, LDL--blood<br/>Data Interpretation, Statistical<br/>Double-Blind Method<br/>Drug Combinations<br/>Ezetimibe<br/>Female<br/>Humans<br/>Hypercholesterolemia--drug therapy<br/>Male<br/>Middle Aged<br/>Simvastatin--administration & dosage<br/>Tablets<br/>Triglycerides--blood